• Suche
0 € Trading
Trading
Suche
0 € Aktienhandel
Wertpapierhandel für 0 Euro
Trading
zero-Trading
ETF-Sparplan

Roche Aktie

343,55EUR
-1,75EUR
-0,51%
26.11.2021
L&S
358,60CHF
-3,45CHF
-0,95%
26.11.2021
SWX

WKN: 855167 / ISIN: CH0012032048

  Kaufen  
Verkaufen
oder
mehr Daten anzeigen
Werbung

Roche Aktien News

  • Sprache:
  • Alle
  • DE
  • EN
  • Sortieren:
  • Datum
  • meistgelesen
26.11.21
Roche Extraordinary General Meeting 2021 (Roche Holding AG)
26.11.21Roche Extraordinary General Meeting 2021 (GlobeNewswire)
23.11.21
Roche to present new pivotal data at ASH 2021 from broad and comprehensive portfolio, challenging treatment standards for people with blood disorders (Roche Holding AG)
23.11.21Roche to present new pivotal data at ASH 2021 from broad and comprehensive portfolio, challenging treatment standards for people with blood disorders (GlobeNewswire)
19.11.21
European Commission approves Roche’s Gavreto (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer (Roche Holding AG)
19.11.21European Commission approves Roche’s Gavreto (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer (GlobeNewswire)
18.11.21
Roche launches cobas 5800, a new molecular diagnostics system to expand access to testing and improve patient care (Roche Holding AG)
18.11.21Roche launches cobas 5800, a new molecular diagnostics system to expand access to testing and improve patient care (GlobeNewswire)
15.11.21
Roche ranked as one of the top three most sustainable healthcare companies in the Dow Jones Sustainability Indices for the thirteenth year running (Roche Holding AG)
15.11.21Roche ranked as one of the top three most sustainable healthcare companies in the Dow Jones Sustainability Indices for the thirteenth year running (GlobeNewswire)
12.11.21
Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease (Roche Holding AG)
12.11.21Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease (GlobeNewswire)
11.11.21
CHMP recommends EU approval of Ronapreve to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease (Roche Holding AG)
11.11.21CHMP recommends EU approval of Ronapreve to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease (GlobeNewswire)
04.11.21
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces the repurchase of the equity stake held by Novartis in Roche (Roche Holding AG)
04.11.21[Ad hoc announcement pursuant to Art. 53 LR] Roche announces the repurchase of the equity stake held by Novartis in Roche (GlobeNewswire)
29.10.21
IMPACT trial data shows clear benefit in using Roche's CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancer (Roche Holding AG)
29.10.21IMPACT trial data shows clear benefit in using Roche's CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancer (GlobeNewswire)
28.10.21Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes (PR Newswire)
28.10.21Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes (PR Newswire)
25.10.21
Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research (Roche Holding AG)
25.10.21Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research (GlobeNewswire)
22.10.21
FDA approves Roche’s Susvimo, a first-of-its-kind therapeutic approach for neovascular or “wet” age-related macular degeneration (nAMD) (Roche Holding AG)
22.10.21FDA approves Roche’s Susvimo, a first-of-its-kind therapeutic approach for neovascular or “wet” age-related macular degeneration (nAMD) (GlobeNewswire)
22.10.21
Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq® (atezolizumab) (Roche Holding AG)
22.10.21Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq® (atezolizumab) (GlobeNewswire)
20.10.21
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in the first nine months - outlook for 2021 raised (Roche Holding AG)
18.10.21Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care (PR Newswire)
18.10.21Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care (PR Newswire)
15.10.21
US FDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer (Roche Holding AG)
15.10.21US FDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer (GlobeNewswire)
15.10.21
Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care (Roche Holding AG)
15.10.21Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care (GlobeNewswire)
14.10.21New four-year data show Roche's ENSPRYNG significantly reduces debilitating relapses in people with neuromyelitis optica spectrum disorder (GlobeNewswire)
14.10.21
New four-year data show Roche's ENSPRYNG significantly reduces debilitating relapses in people with neuromyelitis optica spectrum disorder (Roche Holding AG)
14.10.21Roche’s Gazyvaro shorter 90-minute infusion time approved in Europe for people with previously treated or untreated follicular lymphoma (GlobeNewswire)
14.10.21
Roche’s Gazyvaro shorter 90-minute infusion time approved in Europe for people with previously treated or untreated follicular lymphoma (Roche Holding AG)
13.10.21Data up to 8-years for Roche’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression i (GlobeNewswire)
08.10.21
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s anti-amyloid beta antibody gantenerumab granted FDA Breakthrough Therapy Designation in Alzheimer’s disease (Roche Holding AG)
08.10.21[Ad hoc announcement pursuant to Art. 53 LR] Roche’s anti-amyloid beta antibody gantenerumab granted FDA Breakthrough Therapy Designation in Alzheimer’s disease (GlobeNewswire)
Seite: 123456789...13

Roche News

Roche News: auf dieser Seite finden Sie alle Roche News und Nachrichten zur Roche Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Roche News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Roche News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Newssuche

GO
Werbung

Meistgelesene Roche News

04.11.21Roche kauft Novartis für 19 Milliarden Franken heraus - Aktie uneins
12.11.21EU genehmigt Covid-Medikament von Roche - so reagieren die Aktien von BioNTech. Moderna und Valneva
15.11.21Milliardendeal mit Novartis: Ethos lehnt Vernichtung von Roche-Aktien ab
06.11.2119 Milliarden Franken in bar: So entgeht Novartis den Strafzinsen beim Milliardendeal mit Roche
04.11.21Nach Roche- und Sandoz-Deals: Das wird Novartis mit der Riesensumme von rund 50 Milliarden machen
04.11.21Kommentar zum Roche-Novartis-Deal: Die ganze Schweiz profitiert von der Neuordnung in Basel
04.11.21Dividenden-Liebling Roche: Novartis verkauft Aktien-Paket. Aktie spring auf neues Rekordhoch
31.10.21Roche-Aktie: Einschätzungen und Kursziele der Analysten im Oktober
01.11.21Hohe Medikamentenpreise: USA schonen Pharmariesen Roche und Novartis
04.11.21Paukenschlag bei Pharmariesen: Die wichtigsten Punkte zum Roche-Novartis-Milliardendeal
Weitere Roche News

Roche Peer Group News

21:18 UhrModerna-Aktie: Moderna arbeitet seit Thanksgiving an Omikron-Impfstoff
16:30 UhrModerna. Pfizer. and Novavax Are Must-Own Stocks This Week
16:29 UhrKORREKTUR: Moderna arbeitet seit Thanksgiving an Omikron-Impfstoff
27.11.21GESAMT-ROUNDUP: Sorge vor Omikron - Erste Fälle in Deutschland nachgewiesen
27.11.21Zugekauft: Was Novartis mit den Roche-Milliarden macht
27.11.21Kassenärzte: Kontigentierung von BioNTech-Impfstoff dringend ändern
27.11.21Omikron: Impfstoff-Experte geht nicht von Neustart der Pandemie aus
27.11.21EU-Gesundheitsbehörde sorgt sich um Omicron-Folgen für Impfschutz
27.11.21EU-Grünen-Abgeordnete für Freigabe der Corona-Impfpatente
27.11.21EU regulator approves BioNTech-Pfizer vaccine for 5-11 age group
finanzen.net zero

Aktien kaufen ohne Kosten

finanzen.net zero
Aktien, ETFs, Derivate, Kryptos und mehr jetzt für 0 Euro pro Trade handeln!
JETZT INFORMIEREN
Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
JETZT MEHR ERFAHREN
Zur klassischen Ansicht wechseln
Hilfe & Kontakt
Impressum
Werben
Presse
mehr anzeigen